Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: An analysis of guidelines and systematic reviews

BMC Family Practice

Volumn 14, Issue , 2013, Pages

  Mercier, Alain ^a   Auger Aubin, Isabelle ^b   Lebeau, Jean Pierre ^c   Schuers, Matthieu ^a   Boulet, Pascal ^a   Hermil, Jean Loup ^a   Van Royen, Paul ^d   Peremans, Lieve ^d,e  

^a UNIVERSITÉ DE ROUEN   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ DE TOURS   (France)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Antidepressants; Family practice; Literature review; Therapeutic use

Indexed keywords

ANTIDEPRESSANT AGENT;

CHRONIC DISEASE; CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; HEALTH SERVICE; HUMAN; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; REVIEW; STANDARD;

ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; HEALTH SERVICES MISUSE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE;

MLCS; MLOWN;

EID: 84876999178     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-14-55     Document Type: Article

References (71)

1. [Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD/MHEDEA 2000 epidemiological study]. Gasquet I, Nègre-Pagès L, Fourrier A, Nachbaur G, El-Hasnaoui A, Kovess V, Lépine J-P, Encephale 2005 31 195 206 10.1016/S0013-7006(05) 82386-3 15959446 (Pubitemid 40684454)
2. National patterns in antidepressant medication treatment. Olfson M, Marcus SC, Arch Gen Psychiatry 2009 66 848 10.1001/archgenpsychiatry.2009.81 19652124
3. Ventes de médicaments aux officines et aux hôpitaux en France: chiffres clés 2010. Rapport d'expertise. (Sales of medicines to pharmacies and hospitals in France: key figures 2010. Expertise) http://ansm.sante.fr/content/download/35989/470166/version/4/file/ chiffres-cle-venteMedicaments2010.pdf
4. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, De Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lépine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martínez-Alonso M, Matschinger H, Acta Psychiatr Scand Suppl 2004 109 55 64
5. [Psychotropic drug use in France: changes over time and comparison with other European countries]. Lepine J, Gasquet IF, Bull Acad Natl Med 2006 190 1139 1145 17195398
6. Are we going to increase the use of antidepressants up to that of benzodiazepines? Ciuna A, Andretta M, Corbari L, Levi D, Mirandola M, Sorio A, Barbui C, Eur J Clin Pharmacol 2004 60 629 634 10.1007/s00228-004-0810-8 15448956 (Pubitemid 40064595)
7. Prevalence, duration and indications for prescribing of antidepressants in primary care. Petty DR, House A, Knapp P, Raynor T, Zermansky A, Age Ageing 2006 35 523 526 10.1093/ageing/afl023 16690637 (Pubitemid 44295644)
8. Utilization, price, and spending trends for antidepressants in the US Medicaid Program. Chen Y, Kelton CML, Jing Y, Guo JJ, Li X, Patel NC, Res Social Adm Pharm 2008 4 244 257 10.1016/j.sapharm.2007.06.019 18794035
9. National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the national comorbidity survey replication. Mojtabai R, Olfson M, J Clin Psychiatry 2008 69 1064 1074 10.4088/JCP.v69n0704 18399725 (Pubitemid 352031588)
10. A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database. Coupland CAC, Dhiman P, Barton G, Morriss R, Arthur A, Sach T, Hippisley-Cox J, Health Technol Assess 2011 15 1 202 iii-iv 21609648
11. [Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey]. Grolleau A, Cougnard A, Bégaud B, Verdoux H, Encéphale 2008 34 352 359 23648727
12. Most antidepressant use in primary care is justified; results of the netherlands study of depression and anxiety. Piek E, van der Meer K, Hoogendijk WJG, Penninx BWJH, Nolen WA, PLoS One 2011 6 14784 10.1371/journal.pone.0014784 21479264
13. Antidepressants versus placebo for depression in primary care. Arroll B, Elley CR, Fishman T, Goodyear-Smith FA, Kenealy T, Blashki G, Kerse N, MacGillivray S, Cochrane Database Syst Rev 2009 Issue 3 rt. No.: CD007954 CD007954 10.1002/14651858
14. Can people with nonsevere major depression benefit from antidepressant medication? Stewart JA, Deliyannides DA, Hellerstein DJ, McGrath PJ, Stewart JW, J Clin Psychiatry 2012 73 518 525 10.4088/JCP.10m06760 22226407
15. Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription database. Serna MC, Cruz I, Real J, Gascó E, Galván L, Eur Psychiatry 2010 25 206 213 20005684
16. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. Moore M, Yuen HM, Dunn N, Mullee MA, Maskell J, Kendrick T, BMJ 2009 339 3999 10.1136/bmj.b3999 19833707
17. Measuring antidepressant prescribing practice in a health care system using administrative data: implications for quality measurement and improvement. Kerr EA, McGlynn EA, Van Vorst KA, Wickstrom SL, Jt Comm J Qual Improv 2000 26 203 216 10749005
18. Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Mojtabai R, Olfson M, Health Aff 2011 30 1434 1442 10.1377/hlthaff.2010.1024
19. Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia medicaid enrollees in 2001. Chen H, Reeves JH, Fincham JE, Kennedy WK, Dorfman JH, Martin BC, J Clin Psychiatry 2006 67 972 982 10.4088/JCP.v67n0615 16848658 (Pubitemid 44049097)
20. Treatment with antidepressant medications in private health plans. Larson MJ, Miller K, Fleming KJ, Adm Policy Ment Health 2007 34 116 126 10.1007/s10488-006-0088-5 16969580
21. Understanding the prescription of antidepressants: a qualitative study among French GPs. Mercier A, Auger-Aubin I, Lebeau J-P, Van Royen P, Peremans L, BMC Fam Pract 2011 12 99 10.1186/1471-2296-12-99 21943348
22. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces-revised recommendations 2004. Brainin M, Barnes M, Baron J-C, Gilhus NE, Hughes R, Selmaj K, Waldemar G, Eur J Neurol 2004 11 577 581 10.1111/j.1468-1331.2004.00867.x 15379736 (Pubitemid 39279947)
23. Haute autorité de santé (HAS), Quelle place pour la prégabaline dans les douleurs neuropathiques (What place for pregabalin in neuropathic pain ?) Paris: HAS 2007
24. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, Nurmikko T, Eur J Neurol 2010 17 1113 e88 10.1111/j.1468-1331.2010. 02999.x 20402746
25. National Institute for Health and Clinical Excellence, The pharmacological management of neuropathic pain in adults in non-specialist settings [CG96] London: National Institute for Health and Clinical Excellence 2010
26. Efficacy of antidepressants as analgesics: a review. Dharmshaktu P, Tayal V, Kalra BS, J Clin Pharmacol 2012 52 6 17 10.1177/0091270010394852 21415285
27. Antidepressants for neuropathic pain: a Cochrane review. Saarto T, Wiffen PJ, J. Neurol. Neurosurg. Psychiatr. 2010 81 1372 1373 10.1136/jnnp.2008.144964 20543189
28. Duloxetine for treating painful neuropathy or chronic pain. Lunn MPT, Hughes RAC, Wiffen PJ, Cochrane Database Syst Rev 2009 Issue 4 rt. No. CD007115 CD007115.pub2 10.1002/14651858
29. Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, Feldman E, Iverson DJ, Perkins B, Russell JW, Zochodne D, Neurology 2011 76 1758 1765 10.1212/WNL.0b013e3182166ebe 21482920
30. Pharmacologic interventions for treating phantom limb pain. Alviar MJM, Hale T, Dungca M, Cochrane Database Syst Rev 2011 Issue 12 rt. No. CD006380 CD006380.pub2 10.1002/14651858
31. Scottish Intercollegiate Guidelines Network (SIGN), Diagnosis and management of headache in adults. A national clinical guideline Edinburgh (Scotland): SIGN 2008
32. EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sándor PS, Eur J Neurol 2009 16 968 981 10.1111/j.1468-1331.2009.02748.x 19708964
33. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Moja L, Cusi C, Sterzi R, Canepari C, Cochrane Database Syst Rev 2005 Issue 3 rt. No. CD002919 CD002919.pub2 10.1002/14651858
34. Agence national d'accréditation et d'évaluation en santé (ANAES), Recommandations pour la pratique clinique CCQ (Céphalées chroniques quotidiennes): Diagnostic, Rôle de l'abus médicamenteux, Prise en charge. (Guidelines for diagnostic, management of Chronic daily headache. Role of Substance-related disorders) Paris: ANAES 2004
35. Agence national d'accréditation et d'évaluation en santé (ANAES), Prise en charge diagnostique et thérapeutique des lombalgies et lombosciatiques communes de moins de 3 mois d'évolution. (Diagnosis and therapeutic management of acute low back pain, and sciatica) Paris: ANAES 2000
36. National Institute for Health and Clinical Excellence (NICE), Low back pain Early management of persistent non-specific low back pain Clinical guidelines, CG88. 2009
37. Antidepressants for non-specific low back pain. Urquhart DM, Hoving JL, Assendelft WJJ, Roland M, van Tulder MW, Cochrane Database Syst Rev 2008 Issue 1 rt. No. CD001703 CD001703.pub3 10.1002/14651858
38. Institute for Clinical Systems Improvement (ICSI), Assessment and management of chronic pain Bloomington (MN): Institute for Clinical Systems Improvement (ICSI) 2009 Nov. 91 p. [187 references]
39. Interventions for the treatment of burning mouth syndrome. Zakrzewska JM, Forssell H, Glenny A-M, Cochrane Database Syst Rev 2005 Issue 1 rt. No. CD002779 CD002779.pub2 10.1002/14651858
40. Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Qaseem A, Snow V, Cross JT Jr, Forciea MA, Hopkins R Jr, Shekelle P, Adelman A, Mehr D, Schellhase K, Campos-Outcalt D, Santaguida P, Owens DK, Ann Intern Med 2008 148 370 378 10.7326/0003-4819-148-5-200803040- 00008 18316755 (Pubitemid 351665468)
41. Antidepressants for agitation and psychosis in dementia. Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P, Cochrane Database Syst Rev 2011 Issue 2 rt. No. CD008191 10.1002/14651858.CD008191.pub2
42. Haute autorité de santé (HAS), Maladie d'Alzheimer et maladies apparentées: prise en charge des troubles du comportement perturbateurs Paris: HAS (Alzheimer's disease and Alzheimer's related diseases. Management of disruptive behaviour). 2009 23449813
43. Therapies for depression in Parkinson's disease. Ghazi-Noori S, Chung TH, Deane K, Rickards HE, Clarke CE, Cochrane Database Syst Rev 2003 Issue 3 rt. No.: CD003465 10.1002/14651858.CD003465
44. Pharmaceutical interventions for emotionalism after stroke. Hackett ML, Yang M, Anderson CS, Horrocks JA, House A, Cochrane Database Syst Rev 2010 Issue 2 rt. No. CD003690 10.1002/14651858.CD003690.pub3
45. Scottish Intercollegiate Guidelines Network, Management of patients with stroke: rehabilitation, prevention and management of complications, and discharge planning A national clinical guideline. 2010 SIGN ISBN 978 1 905813 63 6, June 2010 [Available at http://www.sign.ac.uk/guidelines/fulltext/118/ ]
46. Interventions for preventing depression after stroke. Hackett ML, Anderson CS, House A, Halteh C, Cochrane Database Syst Rev 2008 Issue 3 rt. No. CD003689 CD003689.pub3 10.1002/14651858
47. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Chollet F, Tardy J, Albucher J-F, Thalamas C, Berard E, Lamy C, Bejot Y, Deltour S, Jaillard A, Niclot P, Lancet Neurol 2011 10 123 130 10.1016/S1474-4422(10)70314-8 21216670
48. Clinical guideline for the evaluation and management of chronic insomnia in adults. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M, J Clin Sleep Med 2008 4 487 504 18853708
49. Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. Hoque R, Chesson AL Jr, J Clin Sleep Med 2010 6 79 83 20191944
50. Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis. Young CA, Ellis C, Johnson J, Sathasivam S, Pih N, Cochrane Database Syst Rev 2011 Issue 5 rt. No. CD006981 CD006981.pub2 10.1002/14651858
51. Antidepressants for patients with tinnitus. Baldo P, Doree C, Molin P, McFerran D, Cecco S, Cochrane Database Syst Rev 2012 Issue 9 rt. No. CD003853 10.1002/14651858.CD003853.pub3
52. Lucas M, Bosch R, Cruz F, de Ridder D, Neisius A, Pickard R, Schröder A, Tubaro A, Turner W, 2010 addendum to 2009 urinary incontinence guidelines Arnhem, The Netherlands: European Association of Urology (EAU) 2010 4
53. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults. Mariappan P, Alhasso AA, Grant A, N'Dow JMO, Cochrane Database Syst Rev 2005 Issue 3 rt. No. CD004742 CD004742.pub2 10.1002/14651858
54. Anticholinergic drugs versus other medications for overactive bladder syndrome in adults. Roxburgh C, Cook J, Dublin N, Cochrane Database Syst Rev 2007 D003190
55. Agence Nationale d'Accréditation et d'Évaluation en Santé (ANAES), Prise en charge de l'incontinence urinaire de la femme en médecine générale Paris: ANAES Recommandations. (Guidelines for management of female urinary incontinence in general practice). 2003
56. Selective serotonin reuptake inhibitors for premenstrual syndrome. Brown J, O'Brien PMS, Marjoribanks J, Wyatt K, Cochrane Database of Systematic Reviews Chichester, UK: John Wiley & Sons, Ltd, The Cochrane Collaboration, Brown J, 2009
57. Non-hormonal interventions for hot flushes in women with a history of breast cancer. Rada G, Capurro D, Pantoja T, Corbalán J, Moreno G, Letelier LM, Vera C, Cochrane Database Syst Rev 2010 Issue 9 rt. No. CD004923 10.1002/14651858.CD004923.pub2
58. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, Vardi Y, Wespes E, Eur Urol 2010 57 804 814 10.1016/j.eururo.2010. 02.020 20189712
59. Selective serotonin-reuptake inhibitors in the treatment of premature ejaculation. Moreland AJ, Makela EH, Ann Pharmacother 2005 39 1296 1301 10.1345/aph.1E069 15941821 (Pubitemid 40943183)
60. Antidepressants for smoking cessation. Hughes JR, Stead LF, Lancaster T, Cochrane Database Syst Rev 2007 Issue 1 rt. No. CD000031 10.1002/14651858. CD000031.pub3 (Pubitemid 351820390)
61. National Institute for Health and Clinical Excellence (NICE), Alcohol-use disorders. Diagnosis, assessment and management of harmful drinking and alcohol dependence CG 115 London: National Institute for Health and Clinical Excellence 2011
62. Antidepressants for depression in physically ill people. Rayner L, Price A, Evans A, Valsraj K, Higginson IJ, Hotopf M, Cochrane Database Syst Rev 2010 Issue 3 rt. No. CD007503 CD007503.pub2 10.1002/14651858
63. Is there any evidence to support the use of anti-depressants in painful rheumatological conditions? Systematic review of pharmacological and clinical studies. Perrot S, Javier R-M, Marty M, Le Jeunne C, Laroche F, Rheumatology (Oxford) 2008 47 1117 1123 10.1093/rheumatology/ken110 (Pubitemid 352038213)
64. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JWM, Cochrane Database Syst Rev 2011 Issue 8 rt. No. CD003460 CD003460.pub 10.1002/14651858
65. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Ford AC, Talley NJ, Schoenfeld PS, Quigley EMM, Moayyedi P, Gut 2009 58 367 378 10.1136/gut.2008. 163162 19001059
66. Are chronic fatigue syndrome and fibromyalgia the same? Implications for the provision of appropriate mental health intervention. McKay PG, Duffy T, Martin CR, J Psychiatr Ment Health Nurs 2009 16 884 894 10.1111/j.1365-2850. 2009.01464.x 19930362
67. Sociological influences on antidepressant prescribing. Sleath B, Shih Y-CT, Soc Sci Med 2003 56 1335 1344 10.1016/S0277-9536(02)00132-6 12600369 (Pubitemid 36216330)
68. Prescribing potentially inappropriate psychotropic medications to the ambulatory elderly. Mort JR, Aparasu RR, Arch Intern Med 2000 160 2825 2831 10.1001/archinte.160.18.2825 11025793
69. [Factors associated with treatment adequacy of major depressive episodes in France]. Briffault X, Morvan Y, Rouillon F, Dardennes R, Lamboy B, Encéphale 2010 36 Suppl 2 59 72 23648727
70. [Use of services and treatment adequacy of major depressive episodes in France]. Briffault X, Morvan Y, Rouillon F, Dardennes R, Lamboy B, Encéphale 2010 36 Suppl 2 48 58 23648727
71. Management of chronic pain in primary care. Smith BH, Torrance N, Curr Opin Support Palliat Care 2011 5 137 142 10.1097/SPC.0b013e328345a3ec 21415754